Endometrial Cancer
3 competing products in clinical development for Endometrial Cancer.
Pipeline by Phase
Phase 1/21
Phase 22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Sodium Cridanimod + progestin therapy | Xenetic Biosciences | Phase 2 | Terminated | 44 |
| Letrozole + Abemaciclib + LY3023414 + Metformin + Zotatifin + Gedatolisib | eFFECTOR Therapeutics | Phase 2 | Recruiting | 44 |
| Atezolizumab - 28 Day Cycle + Bevacizumab + Ipatasertib + Talazoparib + Trastuzumab emtansine + Tiragolumab + Atezolizumab - 21 Day Cycle + Inavolisib + Letrozole + Giredestrant + Abemaciclib | Eli Lilly | Phase 1/2 | Recruiting | 41 |